Sirius Therapeutics

Developer of RNAi therapies for cardiovascular diseases

placeSan Diego, California, United States calendar_todayFounded 2021 language siriusrna.com

Innovation

14 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,434 times.

YearFilings
20232
20247
202511
20263

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Private equity125%
Coming soon